Long-term protection from naturally acquired immunity against hepatitis E virus reinfection
Xiaohui Liu(Xiamen University), Ningshao Xia(Xiamen University), Chunlan Zhuang(Xiamen University), Xiaowen Hu(Xiamen University), Wenhua Zhu, Changlin Yang, Xia Zang, Kongxin Zhu(Xiamen University), Zizheng Zheng(Xiamen University), Jun Zhang(University of Southern California), Yijun Wang, Yingying Su(Nanjing Medical University), Donglin Liu, Shoujie Huang(Xiamen University), Zhaofeng Bi(Xiamen University), Qi Chen(Xiamen University), Ting Wu(University of California, Los Angeles), Han-Min Jiang, Xingcheng Huang(Xiamen University)
Cited by 0
Related Papers
Recent Progress on the Versatility of Virus-Like Particles
|Vaccines|2020|171
Serum and exosome long non coding RNAs as potential biomarkers for hepatocellular carcinoma
|Journal of Cancer|2018|124
Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2024|70
The role of MAP2 kinases and p38 kinase in acute murine liver injury models
|Cell Death and Disease|2017|65
<p>KLF16 Affects the MYC Signature and Tumor Growth in Prostate Cancer</p>
|OncoTargets and Therapy|2020|62